Bliss GVS Pharma Investor Relations Material
Latest events
Q4 24/25
2 May, 2025
Q3 24/25
28 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bliss GVS Pharma Limited
Access all reports
Bliss GVS Pharma Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company offers dosage forms including suppositories, tablets, capsules, dry syrups, creams, and ointments across therapeutic segments such as anti-malarial, dermatology, gynecology, and anti-infectives. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
506197
Country
🇮🇳 India